Fibrolamellar hepatocellular carcinoma mimicking ornithine transcarbamylase deficiency

17Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We report an unusual case of recurrent non-hepatic hyperammonaemic encephalopathy in an adult patient. She had a previous history of treated fibrolamellar hepatocellular carcinoma (FLC). This posed a diagnostic challenge, as she had normal liver function tests and normal looking liver on imaging but with extra hepatic metastases. This case highlights the importance of measuring plasma ammonia levels in all patients presenting with unexplained acute confusion. Clinical awareness of non-hepatic hyperammonaemic encephalopathy can contribute to early diagnosis and timely initiation of life-saving treatment. Delay in treatment results in irreversible brain damage, deep coma and death. Treatment of hyperammonaemia must begin prior to confirmation of aetiology, for a favourable outcome. This case also highlights the need for further research to understand the exact mechanism of hyperammonaemia in hepatocellular carcinoma.

Cite

CITATION STYLE

APA

Sulaiman, R. A., & Geberhiwot, T. (2014). Fibrolamellar hepatocellular carcinoma mimicking ornithine transcarbamylase deficiency. In JIMD Reports (Vol. 16, pp. 47–50). Springer. https://doi.org/10.1007/8904_2014_318

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free